Fri, January 6, 2023

Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $18 on, Jan 6th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-18-on-jan-6th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $20 to $18 on, Jan 6th, 2023.

Puneet has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Puneet


  • Andrea Tan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Thursday, December 15th, 2022
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022